| This article has been cited by |
| 1 | Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study | |
| Jingyu Lin,Yunai Su,Chunxia Wang,Fude Yang,Yi Xu,Yonggui Yuan,Yefeng Yuan,Xiaoping Wang,Xin Yu,Tianmei Si |
| Journal of Psychiatric Research.2018;99()104 |
| [DOI] |
|
| 2 | A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms | |
| David S. Baldwin,Ioana Florea,Paula L. Jacobsen,Wei Zhong,George G. Nomikos |
| Journal of Affective Disorders.2016;206()140 |
| [DOI] |
|
| 3 | Efficacy and safety of escitalopram in treatment of severe depression in Chinese population | |
| Tianmei Si,Gang Wang,Fude Yang,Yiru Fang,Maosheng Fang,Jijun Li,Jicheng Dong,Xinhua Shen,Jianmin Zhuo,Qing Rui,Jinan Wang,Hu Cuili |
| Metabolic Brain Disease.2017;32(3)891 |
| [DOI] |
|
| 4 | Efficacy of escitalopram oxalate for patients with post-stroke depression | |
| Ji-hua Xu,Peng Jiang |
| Medicine.2018;97(14)e0219 |
| [DOI] |
|
| 5 | CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression | |
| Rodrigo Bernini de Brito,Paulo César Ghedini |
| Heliyon.2020;6(5)e04015 |
| [DOI] |
|
| 6 | Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects | |
| J. M. Cooper,J. A. Brown,R. Cairns,G. K. Isbister |
| Clinical Toxicology.2017;55(1)18 |
| [DOI] |
|
| 7 | Assessment of health-related quality of life, mental health status and psychological distress based on the type of pharmacotherapy used among patients with depression | |
| Drishti Shah,Varun Vaidya,Amit Patel,Mary Borovicka,Monica-Holiday Goodman |
| Quality of Life Research.2017;26(4)969 |
| [DOI] |
|
| 8 | Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial | |
| Cheolmin Shin,Sang Won Jeon,Seung-Hoon Lee,Chi-Un Pae,Narei Hong,Hyun Kook Lim,Ashwin A. Patkar,Prakash S. Masand,Hyonggin An,Changsu Han |
| Clinical Psychopharmacology and Neuroscience.2023;21(1)135 |
| [DOI] |
|
| 9 | Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder | |
| Min Lin,Jianying Zhu,Yonggui Yuan,Lie Ren,Mincai Qian,Zhongxia Shen,Yongliang Shao,Xinhua Shen |
| Genetic Testing and Molecular Biomarkers.2018;22(3)199 |
| [DOI] |
|
| 10 | Anisocoria Associated With Escitalopram | |
| Atakan Yucel,Nermin Yucel,Ali Ibis,Halil Ozcan |
| Journal of Clinical Psychopharmacology.2015;35(4)483 |
| [DOI] |
|
